Daily Briefing

Data from the third annual end-of-life care survey by the University of Massachusetts Medical School show Massachusetts is starting to see "the first signs of real change," according to Atul Gawande, co-chair of the Massachusetts Coalition for Serious Illness Care. More

The United States today allocates more of its economic resources toward health care than any other country, and the country fares far worse on several health outcomes than a number of peer countries—but this wasn't always the case, Austin Frakt writes for the New York Times' "The Upshot." Here's what experts think might explain the divergence. More

Robert Wilkie currently serves as acting Veterans Affairs secretary and as the undersecretary of defense for personnel and readiness. More

A small but growing number of hospitals—including Brigham and Women's Hospital and Mount Sinai—are providing in-home treatment for patients who present at the ED with conditions that would typically merit hospitalization. More

Lucemyra is expected to be commercially available on the U.S. market in August, according to drugmaker US WorldMeds. More

FDA on Thursday approved the first in a new class of drugs designed to prevent migraines in adults—a move that some providers said could revolutionize patient care. More

HHS Secretary Alex Azar, whose department must sign off on Vermont's drug importation plan, has been critical of proposals to allow drug imports from Canada and other foreign countries. More

What CDC wants you to know before you take dip in the hotel swimming pool, a new form of synesthesia makes its debut, and more, in our reading list for your weekend. More

CDC and FDA this week said the romaine lettuce linked to an outbreak of E. coli is no longer available for sale, in today's bite-sized hospital and health industry news from Arizona, Tennessee, and Texas. More